Skip to main content

Table 5 Statistical analysis of epilepsy patient’s adherence towards treatment using multiple linear cox regression analysis

From: Analysis of treatment adherence and cost among patients with epilepsy: a four‐year retrospective cohort study in Pakistan

Risk factors Cox Regression Analysis
Controla/Casesb ORc CId (95%)
Age   2.04 (1.61-2.58)
Patients with migraine
 Yes 310/687 2.21 (1.79-2.74)
 No 5331/2910 1.00  
Psychiatric disorders    
 Yes 137/999 4.28 (3.63-4.93)
 No 5504/2598 1.00  
Patients with other comorbidities
 Yes 207/586 1.52 (1.29-1.75)
 No 5434/3011 1.00  
Class of drugs
 Levetiracetam 2042/1224 0.69 (0.55-0.86)
 Valproic acid 1158/452 0.52 (0.46-0.58)
 Carbamazepine 745/564 0.81 (0.69-0.96)
 Lamotrigine 780/305 0.80 (0.68-0.95)
 Lacosamide 614/310 0.65 (0.51-0.82)
 Others 299/743 2.35 (1.93-2.88)
  1. Phenobarbital, phenytoin, gabapentin, pregabalin and oxcarbazepine were categorized as others AEDs
  2. aContinuers, bDiscontinuer, cOdds Ratios, dConfidence interval